Article, 2024

Antidepressant use and ovarian cancer risk: Evidence from nationwide studies with >14,000 cases from Denmark and Sweden

MATURITAS, ISSN 0378-5122, Volume 185, 10.1016/j.maturitas.2024.108009

Contributors

Zheng, Guoqiao (Corresponding author) [1] Baandrup, Louise 0000-0002-5773-5169 [1] Wang, Jiangrong [2] Hertzum-Larsen, Rasmus [1] Hannibal, Charlotte Gerd 0000-0002-1679-6440 [1] Morch, Lina S. [1] Faber, Mette T. [1] Sundstrom, Karin [2] [3] Kjaer, S. K. 0000-0002-8347-1398 [1] [4] [5]

Affiliations

  1. [1] Danish Canc Inst, Canc & Med, Copenhagen, Denmark
    2. [NORA names: DCRC Danish Cancer Society Research Center; Non-Profit Organisations; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
    3. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  3. [3] Karolinska Univ Hosp, Clin Pathol & Canc Diagnost, Med Diagnost Karolinska, Stockholm, Sweden
    4. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  4. [4] Univ Copenhagen, Dept Gynecol, Rigshosp, Copenhagen, Denmark
    5. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  5. [5] Univ Copenhagen, Dept Gynecol, Rigshosp, Copenhagen, Denmark
    6. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Depression, Ovarian tumors, Pharmacoepidemiology, Selective serotonin reuptake inhibitors, Tricyclic antidepressants

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+